(Q43675022)

25 November 2017

Development and in vitro efficacy of novel MMP2 and MMP9 specific doxorubicin albumin conjugates (English)

1 reference

25 November 2017

1 reference

Kratz F

1

1 reference

25 November 2017

Drevs J

2

1 reference

25 November 2017

Bing G

3

1 reference

25 November 2017

Stockmar C

4

1 reference

25 November 2017

Scheuermann K

5

1 reference

25 November 2017

Lazar P

6

1 reference

25 November 2017

Unger C

7

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

25 November 2017

1 reference

25 November 2017

11

1 reference

25 November 2017

2001-2006

1 reference

25 November 2017

15

1 reference

Tumor cell interactions with the extracellular matrix during invasion and metastasis

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

Membrane proteases in focus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

Matrix metalloproteinase inhibitors: applications in oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

Clinical potential of matrix metalloprotease inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

Serum proteins as drug carriers of anticancer agents: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

A novel macromolecular prodrug concept exploiting endogenous serum albumin as a drug carrier for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mamma carcinoma model

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

Continuously recording fluorescent assays optimized for five human matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

Alkylating derivatives of amino acids and peptides. Synthesis of N-maleoylamino acids, [1-(N-maleoylglycyl)cysteinyl]oxytocin. Effects on vasopressin-stimulated water loss from isolated toad bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

High-performance liquid chromatographic studies on non-mercapt in equilibrium with mercapt conversion of human serum albumin. II

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

Rapid analysis of human serum albumin by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900354-7

7 January 2021

10.1016/S0960-894X(01)00354-7

Identifiers

DOI

1 reference

25 November 2017

1 reference